Inhibiting Lck phosphorylation with a small-molecule inhibitor blocked pseudopodia formation and significantly reduced tumor size and stemness in vivo, highlighting Lck’s therapeutic potential in glioblastoma treatment. This evidence concerns the gene LCK and glioblastoma.